AMR 2022 Stakeholder Guide
iiCON: Infection Innovation Consortium
Focus area/active in: Human Health, One Health, Therapeutics, Diagnostics
Company/Organisation type: Association | Cluster | Network
iiCON is a global collaborative infectious disease R&D programme. Founded in 2020 with government funding provided through UKRI’s Strength in Places Fund, the £174 million programme brings together industry, academia, & the NHS in a concerted effort to combat the growing global threat posed by infectious diseases & save lives through collaborative innovation. Led by Liverpool School of Tropical Medicine, our consortium partners Unilever, Liverpool University Hospitals Foundation Trust, University of Liverpool, Evotec, & Infex Therapeutics are working on innovative & ambitious programmes across iiCON’s ten specialist research platforms.
iiCON is designed to facilitate, nurture, and accelerate innovation.
Get in touch!
Dr Becky Jones-Phillips
Business Development Manager
Please fill out the form below to get in touch with us.